Search results
Results from the WOW.Com Content Network
Despite operating for nearly two decades without profit, 23andMe went public in 2021 and reached a $6 billion valuation. The company's stocks were priced at $11.13 a share, but they've fallen ...
Around a year ago, 23andMe had a data breach that led to 6.9 million profiles being accessible. Now, the company has agreed to pay a $30 million settlement after a class-action lawsuit was brought ...
The FDA instructed 23andMe to stop marketing its genetic health screening service in the United States until it completed the agency's regulatory review process. The company could continue selling ...
The 23andMe data leak was a data breach at personal genomics company 23andMe reported in October 2023. The cyberattack gathered profile and ethnicity information from millions of users. The affected customers were reported as primarily Ashkenazi Jews but also including hundreds of thousands of ethnically Chinese users. [ 1 ]
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers' DNA and other data. On Tuesday, 23andMe released its latest earnings ...
23andMe's premier health offers exome sequencing reports, comprehensive blood tests for 55+ biomarkers, a hereditary cancer report and more. $99 per month at 23andMe The product experts at ...
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
A law firm representing around 5,000 customers of genetic testing company 23andMe has raised objections to a proposed $30 million class action settlement, arguing the settlement is intentionally ...